|Delayed - 07/23 04:00:00 pm|
IOVANCE BIOTHERAPEUTICS, INC. : Change in Directors or Principal Officers, Submission of Matters to a Vote of Security Holders (form 8-K)
|06/14/2021 | 05:15pm|
Item 5.02 Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain
As previously disclosed, on
Company (as defined below) that she would be resigning as President, Chief
Executive Officer and a director of the Company to pursue other opportunities.
Item 5.07 Submission of Matters to a Vote of Security Holders.
Annual Meeting of Stockholders
Company's Annual Meeting of Stockholders (the "Annual Meeting") virtually, via
live webcast. At the Annual Meeting, the Company's stockholders voted on three
proposals, each of which is described in more detail in the Company's Definitive
Proxy Statement on Schedule 14A, which was filed with the
shares, or approximately 84.8% of all shares of the Company's common stock
outstanding as of the record date, were present either in person or by proxy.
The following is a brief description of each matter voted upon and the certified
results, including the number of votes cast for and against each matter and, if
applicable, the number of abstentions and broker non-votes with respect to each
· Proposal 1: a proposal to elect
until the Company's 2022 Annual Meeting of Stockholders;
· Proposal 2: a proposal to approve, on a non-binding advisory basis, the
compensation of the Company's named executive officers; and
· Proposal 3: a proposal to ratify the appointment of
Company's independent registered public accounting firm for the fiscal year
In addition, there were 5,931,046 broker non-votes in connection with this
Proposal 2: This proposal was approved with 118,723,536 "FOR" votes, 3,968,157
"AGAINST" votes and 399,998 "ABSTAIN" votes. There were 5,931,046 broker
non-votes in connection with this proposal.
Proposal 3: This proposal was approved with 128,679,733 "FOR" votes, 34,761
"AGAINST" votes and 308,243 "ABSTAIN" votes. There were 0 broker non-votes in
connection with this proposal.
© Edgar Online, source